Global Diagnostic Specialty Antibodies Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Diagnostic Specialty Antibodies Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Application (Oncology Diagnosis, Hepatitis Diagnosis, Infectious Disease Diagnosis, and Others), End-User (Diagnostic Laboratories, and Hospitals), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Diagnostic Specialty Antibodies Market was valued at USD 39,300.7 million in 2023 and is expected to reach USD 61,235.1 million by 2031 while growing at a CAGR of 5.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global diagnostic specialty antibodies market growth. Diagnostic specialty antibodies, proteins produced by the immune system, are specifically designed for medical testing to bind to antigens, detecting and identifying molecules, pathogens, or biomarkers in biological samples like blood, serum, urine, or tissue.
Increasing demand for personalized medicine and continuous advancements in antibody engineering and production technologies, such as monoclonal antibody development, recombinant antibody technology, and phage display technology, drive the diagnostic specialty antibodies market. However, high development costs and regulatory challenges hinder market growth.
Furthermore, the global diagnostic specialty antibodies industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Diagnostic Specialty Antibodies Market is segmented among Monoclonal Antibodies, Polyclonal Antibodies, and Others, based on Type. In 2023, Monoclonal Antibodies accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Diagnostic Specialty Antibodies Market is segmented among Oncology Diagnosis, Hepatitis Diagnosis, Infectious Disease Diagnosis, and Others, based on Type. In 2023, Oncology Diagnosis accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Diagnostic Specialty Antibodies Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are F. Hoffmann-La Roche AG, Abcam plc, Abbott Laboratories, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Creative Diagnostics, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGaA, and Sartorius AG.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Diagnostic Specialty Antibodies Market Dynamics
Drivers
Restraints
Opportunity
4. Global Diagnostic Specialty Antibodies Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Diagnostic Specialty Antibodies Market Segmentation, By Type
Global Diagnostic Specialty Antibodies Market Share Analysis, By Type
Global Diagnostic Specialty Antibodies Market Growth Analysis, By Type
Global Diagnostic Specialty Antibodies Market Trends, By Type
o Monoclonal Antibodies
o Polyclonal Antibodies
o Others
6. Global Diagnostic Specialty Antibodies Market Segmentation, By Application
Global Diagnostic Specialty Antibodies Market Share Analysis, By Application
Global Diagnostic Specialty Antibodies Market Growth Analysis, By Application
Global Diagnostic Specialty Antibodies Market Trends, By Application
o Oncology Diagnosis
o Hepatitis Diagnosis
o Infectious Disease Diagnosis
o Others
7. Global Diagnostic Specialty Antibodies Market Segmentation, By End-User
Global Diagnostic Specialty Antibodies Market Share Analysis, By End-User
Global Diagnostic Specialty Antibodies Market Growth Analysis, By End-User
Global Diagnostic Specialty Antibodies Market Trends, By End-User
o Diagnostic Laboratories
o Hospitals
8. Global Diagnostic Specialty Antibodies Market Segmentation, By Region
Global Diagnostic Specialty Antibodies Market Share Analysis, By Region
Global Diagnostic Specialty Antibodies Market Growth Analysis, By Region
Global Diagnostic Specialty Antibodies Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
F. Hoffmann-La Roche AG*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Abcam plc
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Creative Diagnostics
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company
Merck KGaA
Sartorius AG
*Similar analysis will be provided for each company listed above.
